The landscape of diabetes management is rapidly evolving, and cellular therapy are emerging as a remarkably innovative area of investigation. While conventional therapies often focus on controlling blood glucose levels and addressing complications, cell-based intervention holds the potential to address the underlying causes of Type-2 diabetes. Scie